出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年4月
Rapid Microbiology Testing Market – Global Forecast To 2029
微生物迅速検査市場 : 製品 [機器 (自動識別システム、PCR、質量分析計) 試薬、キット]、メソッド (増殖、核酸、生存率)、用途 (臨床診断、産業、研究) – 2029年までの世界予測
Rapid Microbiology Testing Market by Product (Instruments (Automated Identification System, PCR, Mass Spectrometer) Reagent, Kits), Method (Growth, Nucleic Acid, Viability), Application (Clinical Diagnosis, Industrial, Research) – Global Forecast to 2029
| ページ数 | 318 |
| 図表数 | 363 |
| 価格 | |
| シングルユーザライセンス | USD 4,950 |
| マルチユーザライセンス（5名） | USD 6,650 |
| コーポレート（サイト）ライセンス | USD 8,150 |
| エンタープライズライセンス | USD 10,000 |
| 種別 | 英文調査報告書 |
Report Overview
The rapid microbiology testing market is valued at an estimated USD 5.2 billion in 2024 and is projected to reach USD 8.3 billion by 2029 at a CAGR of 10.1% during the forecast period.
微生物迅速検査市場は、2024 年に推定 52 億米ドルと評価され、予測期間中に 10.1% の CAGR で 2029 年までに 83 億米ドルに達すると予測されています。
There has been a gradual shift from traditional microbiology testing to rapid testing methods in recent years due to the introduction of newer and faster technologies. These technologies eliminate the need for biological amplification of bacteria, making detection quicker and more efficient. Microbial testing has overcome the limitations of long procedural times and exposure to pathogenic strains associated with conventional testing methods. With continuous developments in efficacy, efficiency, accuracy, faster results, and improved functionality, technological advancements in microbiology testing have generated increased interest among clinical laboratories, hospitals, academic institutes, research laboratories, and pharmaceutical & biotechnology companies.
“Reagents & kits segment accounted for the highest growth rate in the rapid microbiology testing market, by product, during the forecast period.”
The rapid microbiology testing market is bifurcated into instruments, reagents & kits, and consumables. The reagents & kits segment in the rapid microbiology testing market is experiencing substantial growth. Major factors driving the growth of this segment include the increasing number of infectious disease diagnostic tests carried out, easy accessibility to a wide range of reagents, and the growing need for more reliable, more specific, and faster detection of microbes in the early stages.
“Nucleic acid-based rapid microbiology testing segment accounted for the highest growth rate in the rapid microbiology testing market, by method, during the forecast period.”
The rapid microbiology testing market is bifurcated into growth-based, cellular component-based, nucleic acid-based, viability-based, and other rapid microbiology testing methods based on method. Nucleic acid-based rapid microbiology testing segment is expected to account for the highest CAGR during the forecast period. The rapid growth of this segment is driven by a combination of technological advancements, greater accuracy, and customization capabilities.
“Asia Pacific: The fastest-growing region rapid microbiology testing market.”
The worldwide market for rapid microbiology testing is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. Emerging economies in this geographical area are observing an upswing in their gross domestic products (GDPs) along with a noteworthy increase in disposable income levels. Consequently, there has been a surge in healthcare expenditure among a larger segment of the population. This trend can be attributed to the sizable patient population and the presence of numerous low-cost device manufacturers in the region.
The break-up of the profile of primary participants in the rapid microbiology testing market:
• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa- 4%
The key players in rapid microbiology testing market are bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Sartorius AG (Germany), Bruker (US), QuidelOrtho Corporation (US), Charles River Laboratories (US), Neogen Corporation (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Gradientech (Sweden), rqmicro AG (Switzerland), Colifast AS (Norway), Serosep Limited (Ireland), Solus PerkinElmer (US), BTNX Inc. (Canada), R-Biopharm AG (Germany), Paragon Genomics, Inc. (US), Kypha Inc. (US), Vivione Biosciences (US), Bactest Ltd. (UK), and CorDx (US).
Research Coverage:
This research report categorizes the rapid microbiology testing market by product (Instruments (automated microbial identification & antimicrobial susceptibility testing systems, mass spectrometers, PCR systems, bioluminescence & fluorescence-based detection systems, cytometers, active air samplers, other instruments), reagents & kits (sterility testing reagents & kits and other reagents & kits), and consumables), by method (Growth-based rapid microbiology testing, cellular component-based rapid microbiology testing, nucleic acid-based rapid microbiology testing, viability-based rapid microbiology testing, and other rapid microbiology testing methods), by application (Clinical disease diagnosis, industrial testing (food & beverage testing, pharmaceutical & biological drug testing, environmental testing, cosmetics & personal care products testing, and other industrial testing applications), and research applications), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the rapid microbiology testing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches and recent developments associated with the rapid microbiology testing market. Competitive analysis of upcoming startups in the rapid microbiology testing market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall rapid microbiology testing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (Increasing incidence of infectious diseases and cancer, technological advancements in rapid microbiology testing, increased funding for R&D and Increased focus on early detection of infectious diseases), opportunities (Growth opportunities in emerging countries), restraints (High capital investments and low cost-benefit ratio and nfavorable regulatory and reimbursement scenario), and challenges (Operational barriers) influencing the growth of the rapid microbiology testing market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the rapid microbiology testing market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the rapid microbiology testing market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the rapid microbiology testing market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like bioMérieux SA (France), Becton, Dickinson and Company (US), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific Inc. (US).
Table of Contents
1 INTRODUCTION 44
1.1 STUDY OBJECTIVES 44
1.2 MARKET DEFINITION 44
1.3 INCLUSIONS & EXCLUSIONS 45
1.4 STUDY SCOPE 46
1.4.1 RAPID MICROBIOLOGY TESTING MARKET 46
1.4.2 REGIONS COVERED 47
1.4.3 YEARS CONSIDERED 47
1.4.4 CURRENCY CONSIDERED 48
1.5 RESEARCH LIMITATIONS 48
1.6 STAKEHOLDERS 48
1.7 SUMMARY OF CHANGES 48
2 RESEARCH METHODOLOGY 50
2.1 RESEARCH DATA 50
2.2 RESEARCH APPROACH 50
FIGURE 1 RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY 50
2.2.1 SECONDARY DATA 51
2.2.1.1 Key data from secondary sources 52
2.2.2 PRIMARY DATA 53
2.2.2.1 Primary sources 53
2.2.2.2 Key data from primary sources 54
2.2.2.3 Key industry insights 55
2.2.2.4 Breakdown of primary interviews 55
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 55
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 56
2.3 MARKET SIZE ESTIMATION 56
2.3.1 BOTTOM-UP APPROACH 57
2.3.1.1 Approach 1: Company revenue estimation approach 57
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 57
2.3.1.2 Approach 2: Presentations of companies and primary interviews 57
2.3.1.3 Growth forecast 58
2.3.1.4 CAGR projections 58
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 58
2.3.2 TOP-DOWN APPROACH 58
FIGURE 6 RAPID MICROBIOLOGY TESTING MARKET: TOP-DOWN APPROACH 59
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 60
FIGURE 7 DATA TRIANGULATION METHODOLOGY 60
2.5 MARKET SHARE 61
2.6 STUDY ASSUMPTIONS 61
2.7 GROWTH RATE ASSUMPTIONS 61
2.8 RISK ASSESSMENT 62
2.8.1 RISK ASSESSMENT: RAPID MICROBIOLOGY TESTING MARKET 62
2.9 RECESSION IMPACT 62
3 EXECUTIVE SUMMARY 64
FIGURE 8 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2024 VS. 2029 (USD MILLION) 64
FIGURE 9 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD,
2024 VS. 2029 (USD MILLION) 65
FIGURE 10 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION) 66
FIGURE 11 RAPID MICROBIOLOGY TESTING MARKET, BY REGION,
2024 VS. 2029 (USD MILLION) 66
4 PREMIUM INSIGHTS 68
4.1 RAPID MICROBIOLOGY TESTING MARKET OVERVIEW 68
FIGURE 12 GROWING FOCUS ON EARLY DETECTION OF DISEASES TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD 68
4.2 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 69
FIGURE 13 INSTRUMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 69
4.3 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024 VS. 2029 (USD MILLION) 69
FIGURE 14 GROWTH-BASED RAPID MICROBIOLOGY TESTING SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 69
4.4 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 70
FIGURE 15 INDUSTRIAL TESTING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 70
4.5 RAPID MICROBIOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 70
FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN RAPID MICROBIOLOGY TESTING MARKET DURING FORECAST PERIOD 70
5 MARKET OVERVIEW 71
5.1 INTRODUCTION 71
5.2 MARKET DYNAMICS 71
FIGURE 17 RAPID MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71
5.2.1 DRIVERS 72
5.2.1.1 Increasing incidence of infectious diseases and cancer 72
TABLE 1 ESTIMATED NUMBER OF NEW CANCER CASES FOR BOTH GENDERS (AGE: 0–85+), 2022 VS. 2045 73
5.2.1.2 Technological advancements in rapid microbiology testing 73
5.2.1.3 Increased funding for R&D 74
5.2.1.4 Increased focus on early detection of infectious diseases 74
5.2.2 RESTRAINTS 74
5.2.2.1 High capital investments and low cost-benefit ratio 74
5.2.2.2 Unfavorable regulatory and reimbursement scenario 75
5.2.3 OPPORTUNITIES 75
5.2.3.1 Growth opportunities in emerging countries 75
5.2.4 CHALLENGES 75
5.2.4.1 Operational barriers 75
5.3 PRICING ANALYSIS 76
TABLE 2 INDICATIVE PRICING FOR RAPID MICROBIOLOGY TESTING PRODUCTS 76
TABLE 3 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY REGION 76
5.4 PATENT ANALYSIS 77
FIGURE 18 PATENT ANALYSIS FOR PCR SYSTEMS (JANUARY 2014–DECEMBER 2023) 77
5.4.1 LIST OF MAJOR PATENTS 78
5.5 VALUE CHAIN ANALYSIS 78
FIGURE 19 VALUE CHAIN ANALYSIS OF RAPID MICROBIOLOGY TESTING MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 79
5.6 SUPPLY CHAIN ANALYSIS 80
FIGURE 20 RAPID MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS 80
5.7 TRADE ANALYSIS 81
5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS 81
TABLE 4 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION) 81
TABLE 5 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION) 81
5.8 ECOSYSTEM ANALYSIS 81
FIGURE 21 RAPID MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS 82
5.8.1 RAPID MICROBIOLOGY TESTING MARKET: ROLE IN ECOSYSTEM 82
5.9 PORTER’S FIVE FORCES ANALYSIS 83
TABLE 6 RAPID MICROBIOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 83
5.9.1 THREAT OF NEW ENTRANTS 83
5.9.2 THREAT OF SUBSTITUTES 83
5.9.3 BARGAINING POWER OF BUYERS 83
5.9.4 BARGAINING POWER OF SUPPLIERS 83
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 84
5.10 REGULATORY LANDSCAPE 84
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
5.10.2 NORTH AMERICA 85
5.10.2.1 US 85
5.10.2.2 Canada 86
5.10.3 EUROPE 86
TABLE 11 EUROPE: CLASSIFICATION OF DEVICES 86
5.10.4 ASIA PACIFIC 87
5.10.4.1 China 87
5.10.4.2 Japan 87
TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 87
5.10.4.3 India 87
5.10.5 LATIN AMERICA 88
5.10.5.1 Brazil 88
5.10.5.2 Mexico 88
5.10.6 MIDDLE EAST 88
5.10.6.1 Africa 89
5.11 TECHNOLOGY ANALYSIS 89
5.11.1 KEY TECHNOLOGIES 89
5.11.1.1 Automated multiplex PCR systems 89
5.11.2 COMPLEMENTARY TECHNOLOGIES 89
5.11.2.1 Optical immunosensors 89
5.11.2.2 Electrochemical immunosensors 90
5.11.3 ADJACENT TECHNOLOGIES 90
5.11.3.1 MALDI-TOF mass spectrometry 90
5.12 KEY CONFERENCES & EVENTS IN 2024–2025 90
TABLE 13 RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS 90
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 91
5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR RAPID MICROBIOLOGY TESTING MARKET 91
5.13.2 REVENUE SHIFT IN RAPID MICROBIOLOGY TESTING MARKET 92
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 92
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 92
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RAPID MICROBIOLOGY TESTING PRODUCTS 92
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RAPID MICROBIOLOGY TESTING PRODUCTS (%) 93
5.14.2 BUYING CRITERIA 93
FIGURE 23 KEY BUYING CRITERIA FOR RAPID MICROBIOLOGY TESTING PRODUCTS 93
TABLE 15 KEY BUYING CRITERIA FOR RAPID MICROBIOLOGY TESTING PRODUCTS 93
5.15 INVESTMENT & FUNDING SCENARIO 94
FIGURE 24 RAPID MICROBIOLOGY TESTING MARKET: INVESTMENT & FUNDING SCENARIO 94
6 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT 95
6.1 INTRODUCTION 96
TABLE 16 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 96
6.2 INSTRUMENTS 96
TABLE 17 KEY PRODUCTS IN RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET 97
TABLE 18 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 97
TABLE 19 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 98
TABLE 20 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 98
TABLE 21 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 22 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 23 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 100
6.2.1 AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS 100
6.2.1.1 Ease of use compared to conventional identification processes to support market growth 100
TABLE 24 RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS,
BY REGION, 2022–2029 (USD MILLION) 101
TABLE 25 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 101
TABLE 26 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 27 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 28 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 103
6.2.2 MASS SPECTROMETERS 103
6.2.2.1 Rapid results associated with mass spectrometry methods to boost adoption 103
TABLE 29 RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS,
BY REGION, 2022–2029 (USD MILLION) 104
TABLE 30 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 31 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 105
TABLE 32 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 105
TABLE 33 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 106
6.2.3 BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS 106
6.2.3.1 Unwanted detection of non-microbial ATP to limit market adoption 106
TABLE 34 RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 107
TABLE 35 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 36 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 37 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 38 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 109
6.2.4 PCR SYSTEMS 109
6.2.4.1 Growing use of standard PCR, real-time PCR, and qPCR for rapid microbial testing to support growth 109
TABLE 39 RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 110
TABLE 40 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 41 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 42 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 43 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 112
6.2.5 CYTOMETERS 112
6.2.5.1 Ability to detect viable organisms to favor market growth 112
TABLE 44 RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY REGION, 2022–2029 (USD MILLION) 113
TABLE 45 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 46 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 47 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 48 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 115
6.2.6 ACTIVE AIR SAMPLERS 115
6.2.6.1 Convenience and ease of use to drive demand for active air samplers 115
TABLE 49 RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY REGION, 2022–2029 (USD MILLION) 116
TABLE 50 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 51 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 52 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 53 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022–2029 (USD MILLION) 118
6.2.7 OTHER INSTRUMENTS 118
TABLE 54 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 119
TABLE 55 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 56 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 57 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 58 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 121
6.3 REAGENTS & KITS 121
TABLE 59 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2022–2029 (USD MILLION) 121
TABLE 60 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 122
TABLE 61 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 62 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 63 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 64 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
6.3.1 STERILITY REAGENTS & KITS 124
6.3.1.1 Increasing adoption of BET assays to propel market growth 124
TABLE 65 RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY REGION, 2022–2029 (USD MILLION) 124
TABLE 66 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 67 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 68 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 69 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 126
6.3.2 OTHER REAGENTS & KITS 126
TABLE 70 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY REGION, 2022–2029 (USD MILLION) 127
TABLE 71 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 72 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 73 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 74 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 129
6.4 CONSUMABLES 129
6.4.1 DEVELOPMENT OF AUTOMATED ZONE READERS AND DISPENSERS TO DRIVE MARKET GROWTH 129
TABLE 75 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 130
TABLE 76 NORTH AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 77 EUROPE: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 78 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 79 LATIN AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
7 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD 133
7.1 INTRODUCTION 134
TABLE 80 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 134
TABLE 81 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY TESTING METHODS 135
7.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING 135
7.2.1 GROWING DEMAND FOR GROWTH-BASED RAPID MICROBIOLOGY TESTING TO DRIVE MARKET GROWTH 135
TABLE 82 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION) 136
TABLE 83 NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 84 EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 85 ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 86 LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
7.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING 138
7.3.1 HIGH LEVEL OF SENSITIVITY, ACCURACY, AND SPECIFICITY ASSOCIATED WITH THIS METHOD TO BOOST MARKET 138
TABLE 87 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION) 139
TABLE 88 NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 89 EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 90 ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 91 LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
7.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING 141
7.4.1 HIGH ACCURACY ASSOCIATED WITH NUCLEIC ACID-BASED METHODS TO FAVOR MARKET GROWTH 141
TABLE 92 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION) 142
TABLE 93 NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 94 EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 95 ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 96 LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
7.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING 144
7.5.1 NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY TO DRIVE DEMAND 144
TABLE 97 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION) 145
TABLE 98 NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 99 EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 100 ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 101 LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147
7.6 OTHER RAPID MICROBIOLOGY TESTING METHODS 147
TABLE 102 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2022–2029 (USD MILLION) 148
TABLE 103 NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 104 EUROPE: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 105 ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 106 LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
8 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION 151
8.1 INTRODUCTION 152
TABLE 107 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 152
8.1.1 PRIMARY NOTES 152
8.1.1.1 Key industry insights 152
8.2 INDUSTRIAL TESTING 153
TABLE 108 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 153
TABLE 109 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 154
TABLE 110 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 111 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 112 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 113 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 156
8.2.1 FOOD & BEVERAGE TESTING 156
8.2.1.1 Stringent quality control and quality assurance processes to drive market growth 156
TABLE 114 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 157
TABLE 115 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 116 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 117 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 118 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 159
8.2.2 PHARMACEUTICAL & BIOLOGICAL DRUG TESTING 159
8.2.2.1 Improved regulatory scenario for drug development to support market growth 159
TABLE 119 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 160
TABLE 120 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 121 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 122 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 123 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 162
8.2.3 ENVIRONMENTAL TESTING 162
8.2.3.1 Growing focus on environmental monitoring to boost segmental growth 162
TABLE 124 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 163
TABLE 125 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 163
TABLE 126 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 127 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 128 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 165
8.2.4 COSMETICS & PERSONAL CARE PRODUCTS TESTING 165
8.2.4.1 Growing use of rapid microbiology testing in these industries to determine presence of microbes to favor market growth 165
TABLE 129 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 166
TABLE 130 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 131 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 132 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 133 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 168
8.2.5 OTHER INDUSTRIAL TESTING APPLICATIONS 168
TABLE 134 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 169
TABLE 135 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 136 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 137 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 138 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 171
8.3 CLINICAL DISEASE DIAGNOSIS 171
8.3.1 HIGH BURDEN OF INFECTIOUS DISEASES AND HAIS TO PROPEL MARKET GROWTH 171
TABLE 139 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 172
TABLE 140 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 172
TABLE 141 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 142 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 143 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 174
8.4 RESEARCH APPLICATIONS 174
8.4.1 INCREASING NUMBER OF EPIDEMIOLOGY-BASED RESEARCH STUDIES TO DRIVE MARKET GROWTH 174
TABLE 144 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 175
TABLE 145 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 175
TABLE 146 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 147 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 148 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 177
9 RAPID MICROBIOLOGY TESTING MARKET, BY REGION 178
9.1 INTRODUCTION 179
TABLE 149 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION) 179
9.2 NORTH AMERICA 179
FIGURE 25 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT 180
TABLE 150 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 151 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 181
TABLE 152 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 153 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 154 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 183
TABLE 155 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 183
9.2.1 NORTH AMERICA: RECESSION IMPACT 184
9.2.2 US 184
9.2.2.1 Increasing adoption of technologically advanced products in US to favor market growth 184
TABLE 156 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 185
TABLE 157 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 158 US: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 186
TABLE 159 US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 186
TABLE 160 US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 187
9.2.3 CANADA 187
9.2.3.1 Favorable environment for R&D and rising incidence of infectious diseases to drive market 187
TABLE 161 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 188
TABLE 162 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 163 CANADA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 164 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 189
TABLE 165 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 190
9.3 EUROPE 190
TABLE 166 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 167 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 191
TABLE 168 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 169 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 170 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 193
TABLE 171 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 193
9.3.1 EUROPE: RECESSION IMPACT 193
9.3.2 GERMANY 194
9.3.2.1 Rising emphasis on food testing and safety to fuel market growth 194
TABLE 172 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 195
TABLE 173 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 174 GERMANY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 175 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 196
TABLE 176 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 197
9.3.3 UK 197
9.3.3.1 Increasing investments and funding by government to drive market growth 197
TABLE 177 UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 198
TABLE 178 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 179 UK: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 180 UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 199
TABLE 181 UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 200
9.3.4 FRANCE 200
9.3.4.1 Rising R&D expenditure to favor market growth 200
TABLE 182 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 201
TABLE 183 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 184 FRANCE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 185 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 202
TABLE 186 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 203
9.3.5 ITALY 203
9.3.5.1 Increased adoption of advanced diagnostic technologies and growing government healthcare investments to drive market 203
TABLE 187 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 203
TABLE 188 ITALY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 189 ITALY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 190 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 205
TABLE 191 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 205
9.3.6 SPAIN 205
9.3.6.1 Rising geriatric population and improving healthcare infrastructure to boost market growth 205
TABLE 192 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 206
TABLE 193 SPAIN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 194 SPAIN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 207
TABLE 195 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 207
TABLE 196 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 208
9.3.7 RUSSIA 208
9.3.7.1 Increasing access to quality healthcare to propel market growth 208
TABLE 197 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 209
TABLE 198 RUSSIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 199 RUSSIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 200 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 210
TABLE 201 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 211
9.3.8 REST OF EUROPE 211
TABLE 202 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 211
TABLE 203 REST OF EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 204 REST OF EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 205 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 213
TABLE 206 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 213
9.4 ASIA PACIFIC 214
FIGURE 26 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT 215
TABLE 207 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216
TABLE 208 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 216
TABLE 209 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 210 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 211 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 218
TABLE 212 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 218
9.4.1 ASIA PACIFIC: RECESSION IMPACT 219
9.4.2 CHINA 219
9.4.2.1 Rising importance of quality control across food and pharmaceutical industries to drive market growth 219
TABLE 213 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 220
TABLE 214 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 215 CHINA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 216 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 221
TABLE 217 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 222
9.4.3 JAPAN 222
9.4.3.1 Rising geriatric population in Japan to support market growth 222
TABLE 218 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 223
TABLE 219 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 223
TABLE 220 JAPAN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 221 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 224
TABLE 222 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 225
9.4.4 INDIA 225
9.4.4.1 Increasing private and public investments in healthcare systems to drive adoption of rapid microbiology testing products 225
TABLE 223 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 226
TABLE 224 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 225 INDIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 227
TABLE 226 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 227
TABLE 227 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 228
9.4.5 AUSTRALIA 228
9.4.5.1 Increasing awareness about antimicrobial resistance to fuel market 228
TABLE 228 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 229
TABLE 229 AUSTRALIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 230 AUSTRALIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 231 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 230
TABLE 232 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 231
9.4.6 REST OF ASIA PACIFIC 231
TABLE 233 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 231
TABLE 234 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 232
TABLE 235 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 232
TABLE 236 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 233
TABLE 237 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 233
9.5 LATIN AMERICA 234
TABLE 238 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 234
TABLE 239 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 235
TABLE 240 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 235
TABLE 241 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 236
TABLE 242 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 236
TABLE 243 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 237
9.5.1 LATIN AMERICA: RECESSION IMPACT 237
9.5.2 BRAZIL 237
9.5.2.1 Improving healthcare infrastructure and stringent regulations to fuel market 237
TABLE 244 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 238
TABLE 245 BRAZIL: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 238
TABLE 246 BRAZIL: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 239
TABLE 247 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 239
TABLE 248 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 240
9.5.3 MEXICO 240
9.5.3.1 Improving accessibility and affordability of healthcare services to support market growth 240
TABLE 249 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 241
TABLE 250 MEXICO: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 251 MEXICO: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 252 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 242
TABLE 253 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 243
9.5.4 REST OF LATIN AMERICA 243
TABLE 254 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 243
TABLE 255 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 244
TABLE 256 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 244
TABLE 257 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 245
TABLE 258 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 245
9.6 MIDDLE EAST & AFRICA 245
9.6.1 ADVANCEMENTS IN DIAGNOSTIC TECHNOLOGIES AND INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET 245
TABLE 259 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 246
TABLE 260 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 261 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 262 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 247
TABLE 263 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 248
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 248
9.7 GCC COUNTRIES 248
9.7.1 RISING FOCUS ON ADVANCED HEALTH INFRASTRUCTURE TO DRIVE MARKET 248
TABLE 264 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 249
TABLE 265 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 250
TABLE 266 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 250
TABLE 267 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION) 251
TABLE 268 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 251
9.7.2 GCC COUNTRIES: RECESSION IMPACT 251
10 COMPETITIVE LANDSCAPE 253
10.1 INTRODUCTION 253
10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 253
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET 253
TABLE 269 RAPID MICROBIOLOGY TESTING MARKET: STRATEGIES ADOPTED 253
10.3 REVENUE SHARE ANALYSIS 255
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS (2018–2022) 255
10.4 MARKET SHARE ANALYSIS 256
10.4.1 RAPID MICROBIOLOGY TESTING MARKET 256
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) 256
TABLE 270 RAPID MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION 256
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 258
10.5.1 LIST OF EVALUATED VENDORS 258
10.5.2 STARS 258
10.5.3 EMERGING LEADERS 258
10.5.4 PERVASIVE PLAYERS 258
10.5.5 PARTICIPANTS 258
FIGURE 29 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022 259
10.5.6 COMPANY FOOTPRINT 259
FIGURE 30 RAPID MICROBIOLOGY TESTING MARKET: COMPANY FOOTPRINT 259
TABLE 271 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT FOOTPRINT 260
TABLE 272 RAPID MICROBIOLOGY TESTING MARKET: REGIONAL FOOTPRINT 260
TABLE 273 RAPID MICROBIOLOGY TESTING MARKET: APPLICATION FOOTPRINT 260
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES 261
10.6.1 PROGRESSIVE COMPANIES 261
10.6.2 RESPONSIVE COMPANIES 261
10.6.3 DYNAMIC COMPANIES 261
10.6.4 STARTING BLOCKS 261
FIGURE 31 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022 262
10.6.5 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS 263
TABLE 274 RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 263
10.7 VALUATION AND FINANCIAL METRICS OF RAPID MICROBIOLOGY TESTING VENDORS 263
FIGURE 32 EV/EBITDA OF KEY VENDORS 263
FIGURE 33 P/E RATIO OF KEY VENDORS 264
10.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 264
FIGURE 34 PRODUCT/BRAND COMPARISON: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING PRODUCTS 264
10.9 COMPETITIVE SCENARIO 265
10.9.1 PRODUCT LAUNCHES 265
TABLE 275 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2020–JANUARY 2024 265
10.9.2 DEALS 266
TABLE 276 RAPID MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2020–JANUARY 2024 266
10.9.3 EXPANSIONS 267
TABLE 277 RAPID MICROBIOLOGY TESTING MARKET: EXPANSIONS, JANUARY 2020–JANUARY 2024 267
11 COMPANY PROFILES 268
(Business overview, Products offered, Recent Developments, MNM view)*
11.1 KEY PLAYERS 268
11.1.1 BIOMÉRIEUX SA 268
TABLE 278 BIOMÉRIEUX SA: COMPANY OVERVIEW 268
FIGURE 35 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022) 269
TABLE 279 BIOMÉRIEUX SA: PRODUCTS OFFERED 269
TABLE 280 BIOMÉRIEUX SA: PRODUCT LAUNCHES & APPROVALS 271
TABLE 281 BIOMÉRIEUX SA: DEALS 273
TABLE 282 BIOMÉRIEUX SA: OTHER DEVELOPMENTS 274
11.1.2 BECTON, DICKINSON AND COMPANY 275
TABLE 283 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 275
FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 276
TABLE 284 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 276
TABLE 285 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS 277
TABLE 286 BECTON, DICKINSON AND COMPANY: DEALS 278
11.1.3 DANAHER CORPORATION 280
TABLE 287 DANAHER CORPORATION: COMPANY OVERVIEW 280
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 281
TABLE 288 DANAHER CORPORATION: PRODUCTS OFFERED 281
TABLE 289 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS 283
TABLE 290 DANAHER CORPORATION: DEALS 284
TABLE 291 DANAHER CORPORATION: EXPANSIONS 284
11.1.4 ABBOTT LABORATORIES 286
TABLE 292 ABBOTT LABORATORIES: COMPANY OVERVIEW 286
FIGURE 38 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023) 287
TABLE 293 ABBOTT LABORATORIES: PRODUCTS OFFERED 287
TABLE 294 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS 289
11.1.5 THERMO FISHER SCIENTIFIC INC. 291
TABLE 295 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 291
FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 292
TABLE 296 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 292
TABLE 297 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES 294
TABLE 298 THERMO FISHER SCIENTIFIC INC.: DEALS 294
11.1.6 MERCK KGAA 296
TABLE 299 MERCK KGAA: COMPANY OVERVIEW 296
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022) 297
TABLE 300 MERCK KGAA: PRODUCTS OFFERED 297
TABLE 301 MERCK KGAA: DEALS 298
11.1.7 BRUKER 299
TABLE 302 BRUKER: COMPANY OVERVIEW 299
FIGURE 41 BRUKER: COMPANY SNAPSHOT (2022) 300
TABLE 303 BRUKER: PRODUCTS OFFERED 300
TABLE 304 BRUKER: PRODUCT LAUNCHES 301
11.1.8 QUIDELORTHO CORPORATION 302
TABLE 305 QUIDELORTHO CORPORATION: COMPANY OVERVIEW 302
FIGURE 42 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022) 303
TABLE 306 QUIDELORTHO CORPORATION: PRODUCTS OFFERED 303
TABLE 307 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS 305
TABLE 308 QUIDELORTHO CORPORATION: DEALS 306
TABLE 309 QUIDELORTHO CORPORATION: OTHER DEVELOPMENTS 306
11.1.9 SARTORIUS AG 307
TABLE 310 SARTORIUS AG: COMPANY OVERVIEW 307
FIGURE 43 SARTORIUS AG: COMPANY SNAPSHOT (2023) 308
TABLE 311 SARTORIUS AG: PRODUCTS OFFERED 308
11.1.10 CHARLES RIVER LABORATORIES 310
TABLE 312 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 310
FIGURE 44 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022) 311
TABLE 313 CHARLES RIVER LABORATORIES: PRODUCTS OFFERED 311
TABLE 314 CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES 312
TABLE 315 CHARLES RIVER LABORATORIES: DEALS 312
11.1.11 NEOGEN CORPORATION 313
TABLE 316 NEOGEN CORPORATION: COMPANY OVERVIEW 313
FIGURE 45 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022) 314
TABLE 317 NEOGEN CORPORATION: PRODUCTS OFFERED 314
TABLE 318 NEOGEN CORPORATION: PRODUCT LAUNCHES 315
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 316
11.2.1 DON WHITLEY SCIENTIFIC LIMITED 316
11.2.2 RAPID MICRO BIOSYSTEMS, INC. 317
11.2.3 GRADIENTECH 318
11.2.4 PERKINELMER INC. 318
11.2.5 RQMICRO AG 319
11.2.6 COLIFAST AS 319
11.2.7 SEROSEP LIMITED 320
11.2.8 BTNX INC. 320
11.2.9 R-BIOPHARM AG 321
11.2.10 PARAGON GENOMICS, INC. 321
11.2.11 KYPHA INC. 322
11.2.12 VIVIONE BIOSCIENCES 322
11.2.13 BACTEST LTD. 323
11.2.14 CORDX 323
12 APPENDIX 324
12.1 DISCUSSION GUIDE 324
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 328
12.3 CUSTOMIZATION OPTIONS 330
12.4 RELATED REPORTS 330
12.5 AUTHOR DETAILS 331
Table of Contents